SynthesisFrontiers in clinical diabetes and healthcare2026
Dapagliflozin & pioglitazone combination therapy in T2DM with or without MASLD - a systematic review and meta-analysis: PRO-2 study.
Shashank Joshi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.